Market revenue in 2023 | USD 3,124.1 million |
Market revenue in 2030 | USD 7,266.4 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mesenchymal stem cells market will help companies and investors design strategic landscapes.
product was the largest segment with a revenue share of 78.89% in 2023. Horizon Databook has segmented the Global mesenchymal stem cells market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Growing The strong pipeline of MSC-based products is recognized as a major driving force for the global mesenchymal stem cell market. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc.
Furthermore, the number of clinical trials based on MSCs has increased significantly since 2008. According to a study published in July 2020, the number of clinical trials registered at the U.S. FDA that are exploring potential of mesenchymal stem cells has exceeded 1,050.
The number of companies that have or are in process of commercializing MSC-based therapies is increasing. For instance, Takeda/TiGenix phase 3 clinical trial incorporates MSCs for complex perianal fistulas in Crohn's disease. This was the most successful late-stage clinical trial, as of September 2020.
Horizon Databook provides a detailed overview of global-level data and insights on the Global mesenchymal stem cells market , including forecasts for subscribers. This global databook contains high-level insights into Global mesenchymal stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account